Calidi Biotherapeutics Stock Forecast

Sell candidate since Aug 04, 2026 Loss -6.88%

The Calidi Biotherapeutics, Inc. stock price fell by -6.88% on the last day (Wednesday, 5th Aug 2026) from $1.89 to $1.76. During the last trading day the stock fluctuated 11.31% from a day low at $1.68 to a day high of $1.87. The price has fallen in 5 of the last 10 days but is still up by 4.17% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -91 thousand shares and in total, 164 thousand shares were bought and sold for approximately $288.61 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -45.74% during the next 3 months and, with a 90% probability hold a price between $0.735 and $1.10 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CLDI Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 17.90%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Calidi Biotherapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.11. On a fall, the stock will find some support from the short-term average at $1.67. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Calidi Biotherapeutics, Inc. stock

Calidi Biotherapeutics, Inc. finds support from accumulated volume at $1.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.190 between high and low, or 11.31%. For the last week the stock has had daily average volatility of 14.81%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLDI) For The Upcoming Trading Day Of Thursday 6th

For the upcoming trading day on Thursday, 6th we expect Calidi Biotherapeutics, Inc. to open at $1.77, and during the day (based on 14 day Average True Range), to move between $1.64 and $1.88, which gives a possible trading interval of +/-$0.232 (+/-14.12%) up or down from last closing price. If Calidi Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.12% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.68 (4.55%) than the resistance at $1.85 (5.09%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Calidi Biotherapeutics, Inc. stock A Buy?

Calidi Biotherapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.650 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 6, 2026 - $1.77 ( 0.568%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk